A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Clinical trial NCT06655883 · RECRUITING
Trial details
- NCT number
- NCT06655883
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-09
- Primary completion
- 2027-06-24
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.